The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Age Related Macular Degeneration (AMD)-Global Market Insights and Sales Trends 2024
Synopsis
The global Age Related Macular Degeneration (AMD) market size is expected to reach US$ 11400 million by 2029, growing at a CAGR of 5.8% from 2023 to 2029. The market is mainly driven by the significant applications of Age Related Macular Degeneration (AMD) in various end use industries. The expanding demands from the Men and Woman, are propelling Age Related Macular Degeneration (AMD) market. Wet AMD, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Dry AMD segment is estimated at % CAGR for the next seven-year period.
Age related macular degeneration (AMD) is a condition wherein the macula the small central area of the retina in the eye is deteriorated.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Age Related Macular Degeneration (AMD), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Age Related Macular Degeneration (AMD) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Age Related Macular Degeneration (AMD) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Age Related Macular Degeneration (AMD) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Age Related Macular Degeneration (AMD) covered in this report include Bayer, F. HoffmannLa Roche, Regeneron, Novartis, Valeant and Pfizer, etc.
The global Age Related Macular Degeneration (AMD) market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bayer
F. HoffmannLa Roche
Regeneron
Novartis
Valeant
Pfizer
Global Age Related Macular Degeneration (AMD) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Age Related Macular Degeneration (AMD) market, Segment by Type:
Wet AMD
Dry AMD
Global Age Related Macular Degeneration (AMD) market, by Application
Men
Woman
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Age Related Macular Degeneration (AMD) companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Age Related Macular Degeneration (AMD) market size is expected to reach US$ 11400 million by 2029, growing at a CAGR of 5.8% from 2023 to 2029. The market is mainly driven by the significant applications of Age Related Macular Degeneration (AMD) in various end use industries. The expanding demands from the Men and Woman, are propelling Age Related Macular Degeneration (AMD) market. Wet AMD, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Dry AMD segment is estimated at % CAGR for the next seven-year period.
Age related macular degeneration (AMD) is a condition wherein the macula the small central area of the retina in the eye is deteriorated.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Age Related Macular Degeneration (AMD), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Age Related Macular Degeneration (AMD) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Age Related Macular Degeneration (AMD) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Age Related Macular Degeneration (AMD) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Age Related Macular Degeneration (AMD) covered in this report include Bayer, F. HoffmannLa Roche, Regeneron, Novartis, Valeant and Pfizer, etc.
The global Age Related Macular Degeneration (AMD) market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bayer
F. HoffmannLa Roche
Regeneron
Novartis
Valeant
Pfizer
Global Age Related Macular Degeneration (AMD) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Age Related Macular Degeneration (AMD) market, Segment by Type:
Wet AMD
Dry AMD
Global Age Related Macular Degeneration (AMD) market, by Application
Men
Woman
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Age Related Macular Degeneration (AMD) companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Age Related Macular Degeneration (AMD)
1.1 Age Related Macular Degeneration (AMD) Market Overview
1.1.1 Age Related Macular Degeneration (AMD) Product Scope
1.1.2 Age Related Macular Degeneration (AMD) Market Status and Outlook
1.2 Global Age Related Macular Degeneration (AMD) Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Age Related Macular Degeneration (AMD) Market Size by Region (2018-2029)
1.4 Global Age Related Macular Degeneration (AMD) Historic Market Size by Region (2018-2023)
1.5 Global Age Related Macular Degeneration (AMD) Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Age Related Macular Degeneration (AMD) Market Size (2018-2029)
1.6.1 North America Age Related Macular Degeneration (AMD) Market Size (2018-2029)
1.6.2 Europe Age Related Macular Degeneration (AMD) Market Size (2018-2029)
1.6.3 Asia-Pacific Age Related Macular Degeneration (AMD) Market Size (2018-2029)
1.6.4 Latin America Age Related Macular Degeneration (AMD) Market Size (2018-2029)
1.6.5 Middle East & Africa Age Related Macular Degeneration (AMD) Market Size (2018-2029)
2 Age Related Macular Degeneration (AMD) Market by Type
2.1 Introduction
2.1.1 Wet AMD
2.1.2 Dry AMD
2.2 Global Age Related Macular Degeneration (AMD) Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Age Related Macular Degeneration (AMD) Historic Market Size by Type (2018-2023)
2.2.2 Global Age Related Macular Degeneration (AMD) Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Age Related Macular Degeneration (AMD) Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Age Related Macular Degeneration (AMD) Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Age Related Macular Degeneration (AMD) Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Age Related Macular Degeneration (AMD) Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Age Related Macular Degeneration (AMD) Revenue Breakdown by Type (2018-2029)
3 Age Related Macular Degeneration (AMD) Market Overview by Application
3.1 Introduction
3.1.1 Men
3.1.2 Woman
3.2 Global Age Related Macular Degeneration (AMD) Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Age Related Macular Degeneration (AMD) Historic Market Size by Application (2018-2023)
3.2.2 Global Age Related Macular Degeneration (AMD) Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Age Related Macular Degeneration (AMD) Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Age Related Macular Degeneration (AMD) Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Age Related Macular Degeneration (AMD) Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Age Related Macular Degeneration (AMD) Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Age Related Macular Degeneration (AMD) Revenue Breakdown by Application (2018-2029)
4 Age Related Macular Degeneration (AMD) Competition Analysis by Players
4.1 Global Age Related Macular Degeneration (AMD) Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Age Related Macular Degeneration (AMD) as of 2022)
4.3 Date of Key Players Enter into Age Related Macular Degeneration (AMD) Market
4.4 Global Top Players Age Related Macular Degeneration (AMD) Headquarters and Area Served
4.5 Key Players Age Related Macular Degeneration (AMD) Product Solution and Service
4.6 Competitive Status
4.6.1 Age Related Macular Degeneration (AMD) Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Bayer
5.1.1 Bayer Profile
5.1.2 Bayer Main Business
5.1.3 Bayer Age Related Macular Degeneration (AMD) Products, Services and Solutions
5.1.4 Bayer Age Related Macular Degeneration (AMD) Revenue (US$ Million) & (2018-2023)
5.1.5 Bayer Recent Developments
5.2 F. HoffmannLa Roche
5.2.1 F. HoffmannLa Roche Profile
5.2.2 F. HoffmannLa Roche Main Business
5.2.3 F. HoffmannLa Roche Age Related Macular Degeneration (AMD) Products, Services and Solutions
5.2.4 F. HoffmannLa Roche Age Related Macular Degeneration (AMD) Revenue (US$ Million) & (2018-2023)
5.2.5 F. HoffmannLa Roche Recent Developments
5.3 Regeneron
5.3.1 Regeneron Profile
5.3.2 Regeneron Main Business
5.3.3 Regeneron Age Related Macular Degeneration (AMD) Products, Services and Solutions
5.3.4 Regeneron Age Related Macular Degeneration (AMD) Revenue (US$ Million) & (2018-2023)
5.3.5 Novartis Recent Developments
5.4 Novartis
5.4.1 Novartis Profile
5.4.2 Novartis Main Business
5.4.3 Novartis Age Related Macular Degeneration (AMD) Products, Services and Solutions
5.4.4 Novartis Age Related Macular Degeneration (AMD) Revenue (US$ Million) & (2018-2023)
5.4.5 Novartis Recent Developments
5.5 Valeant
5.5.1 Valeant Profile
5.5.2 Valeant Main Business
5.5.3 Valeant Age Related Macular Degeneration (AMD) Products, Services and Solutions
5.5.4 Valeant Age Related Macular Degeneration (AMD) Revenue (US$ Million) & (2018-2023)
5.5.5 Valeant Recent Developments
5.6 Pfizer
5.6.1 Pfizer Profile
5.6.2 Pfizer Main Business
5.6.3 Pfizer Age Related Macular Degeneration (AMD) Products, Services and Solutions
5.6.4 Pfizer Age Related Macular Degeneration (AMD) Revenue (US$ Million) & (2018-2023)
5.6.5 Pfizer Recent Developments
6 North America
6.1 North America Age Related Macular Degeneration (AMD) Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Age Related Macular Degeneration (AMD) Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Age Related Macular Degeneration (AMD) Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Age Related Macular Degeneration (AMD) Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Age Related Macular Degeneration (AMD) Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Age Related Macular Degeneration (AMD) Market Dynamics
11.1 Age Related Macular Degeneration (AMD) Industry Trends
11.2 Age Related Macular Degeneration (AMD) Market Drivers
11.3 Age Related Macular Degeneration (AMD) Market Challenges
11.4 Age Related Macular Degeneration (AMD) Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
